Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT04303013
The purpose of this research is to gather information on the effects of Mindfulness-Based Intervention (MBI) on quality of life during and after radiation treatment.
This study involves randomization. There is a 50 percent chance (like a flip of the coin) that you will be randomized to attend meditation sessions during treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will attend weekly in person guided meditation sessions during the course of their radiation treatment. Patient will complete quality of life surveys before, during and after treatment.
Patient not assigned to meditation will undergo radiation with usual care and complete quality of life surveys before, during and after treatment.
Time frame: Before radiation treatment.
including emotional, physical, functional, and social domains assessed via the FACT-G during and after radiotherapy for the treatment of cancer.
Time frame: During radiation treatment
Comparison of change in total LASA-6 and single question relaxation surveys.
Time frame: 3 months and 12 months post radiation treatment.
Comparison of change in FACT-G, Promis 10 and LASA-6 surveys.
Mayo Clinic
Other
A Randomized Controlled Trial of Guided Mindfulness Intervention During Radiotherapy.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04310410
Bone Cancer, Bone Diseases
Zwolle, Overijsel, Netherlands
View Trial DetailsNCT04075305
Bladder Cancer, Bladder Neoplasm
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06531681
Neoplasms, Oncology
Haikou, China
View Trial DetailsNCT06654869
Cancer, Neoplasms
Erzurum, Yakutiye, Turkey (Türkiye)
View Trial Details